Intra-Cellular Therapies ...

131.87
0.00 (0.00%)
At close: Apr 01, 2025, 3:59 PM

Intra-Cellular Therapies Stock Forecast

Stock Price Forecast

The 13 analysts with 12-month price forecasts for ITCI stock have an median target of 99, with a low estimate of 74 and a high estimate of 132. The median target predicts a decrease of -24.93% from the current stock price of 131.87.

Target Low Average Median High
Price $74 $106.75 $99 $132
Change -43.88% -19.05% -24.93% 0.10%

Latest Analyst Insight Report

Cantor Fitzgerald maintained a Neutral rating on I... Unlock content with Pro Subscription

Updated Apr 02, 2025

Rating Sep 24Oct 24Nov 24Jan 25Feb 25Apr 25
Strong Buy 000000
Buy 341000
Hold 000421
Sell 000000
Strong Sell 000000
Total 3 4 1 4 2 1

Financial Forecast this Year

Revenue This Year
938.19M
from 680.85M
Increased by 37.8%
Revenue Next Year
1.45B
from 938.19M
Increased by 55.0%
EPS This Year
0.66
from -0.72
Increased by 8.3%
EPS Next Year
4.25
from 0.66
Increased by 543.9%